Tiedemann Advisors, LLC Procept Bio Robotics Corp Transaction History
Tiedemann Advisors, LLC
- $2.31 Billion
- Q3 2023
A detailed history of Tiedemann Advisors, LLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Tiedemann Advisors, LLC holds 73,388 shares of PRCT stock, worth $4.67 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
73,388
Previous 86,236
14.9%
Holding current value
$4.67 Million
Previous $3.05 Million
21.03%
% of portfolio
0.1%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding PRCT
# of Institutions
173Shares Held
38.1MCall Options Held
386KPut Options Held
259K-
Cpmg Inc Dallas, TX5.33MShares$339 Million100.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.25MShares$270 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.29MShares$209 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.94MShares$187 Million0.09% of portfolio
-
Alliancebernstein L.P. New York, NY1.99MShares$126 Million0.04% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.84B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...